Viewing Study NCT00016094


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-06-20 @ 8:55 PM
Study NCT ID: NCT00016094
Status: COMPLETED
Last Update Posted: 2013-01-29
First Post: 2001-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaplastic Large Cell Lymphoma View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Mantle Cell Lymphoma View
Keywords: